Takeda Pharmaceutical Co Ltd ADR (TAK)

Takeda Pharmaceutical Co Ltd ADR (TAK) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector listed on the NYSE.

As of Oct 23, 2026: market cap $64.7B; returns 1 day -0.6%, 1 week +2.9%, 1 year +44.0%.

Takeda Pharmaceutical is a leading Japanese global biopharmaceutical company that operates across five primary therapeutic areas: Gastroenterology, Rare Diseases, Plasma-Derived Therapies, Oncology, and Neuroscience.

Groups TAK belongs to

• Dividend Payers
• Pharmaceuticals
• Japan Companies
• Biopharmaceutical
• Healthcare
• Rare Diseases
• Gastroenterology
• Oncology
• Neuroscience
• Plasma Collection
• Commercial Stage Biotech
• Global Operations
• Life Sciences

TAK financial model: income statement, cash flow and balance sheet